Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverJHPCY
HealthcarePNKUSD

JHPCY

$0012345678900123456789.0012345678900123456789+4.1%
52w low $11.50$20.00 52w high
Market data · updated 5h ago
Market data
Market cap
$45.13B
52w range
$11.50 - $20.00
Beta
0.12
Sector
Healthcare
Data quality
100/100
Valuation
P/E ratio
37.8x
fair value estimate
$10.24
Margin of safety
-18.1%
Dividend yield
0.43%
Quality & efficiency
Moat score
82/100
Return on equity
14.5%
Profit margin
24.9%
Growth & analysts
Revenue growth
+13.0%
Run the 10-point checklist before you buy How these numbers are made

About JHPCY

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

Valuation

ValueGrowthProfitHealthIncome50QUALITY
Overall Rating
49
Moderate quality
Moderate quality

Derived from filed metrics · High confidence (100% of the inputs available)

Moat Score82
Fair value estimate
$10.24-18.1% downside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$45.13B
P/E Ratio
37.8
Dividend Yield
0.43%
Revenue Growth
+13.0%
Profit Margin
24.9%
ROE
14.5%
Debt / Equity
0.00
Beta
0.12

Statistics

Similar Stocks · Healthcare

Latest News · JHPCY